LABORATORY RESEARCH USE ONLY. NOT INTENDED FOR CONSUMPTION.

Ipamorelin — Published Research

Reviewed by: James S.| Last updated: April 29, 2026|For laboratory reference only

← Back to Ipamorelin product page

How to read this Ipamorelin research page

This page summarizes Ipamorelin literature by experimental theme, including ghrelin-receptor signaling, selectivity assays, and pituitary model-system research. It is a literature map, not a protocol or human-use resource.

Panda Peptides products are for research use only. No dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance is provided.

Research Library

Published research on ipamorelin — for educational purposes only

Ipamorelin Selectivity as a GH Secretagogue

In swine pituitary cell cultures, ipamorelin stimulated GH release with an EC₅₀ of approximately 1.3 nM. At effective concentrations, the peptide did not alter ACTH, cortisol, prolactin, FSH, or LH levels in vivo. This selectivity profile was confirmed in both rat and dog models. Comparison studies showed that GHRP-6 and GHRP-2 at comparable concentrations produced significant increases in cortisol and prolactin, while ipamorelin did not, establishing it as the first truly selective GHS. For laboratory research use only.

Raun K et al. “Ipamorelin, the first selective ghrelin-receptor agonist.” Eur J Endocrinol. 1998. PubMed

GHS-R1a Receptor Signaling Mechanism

Ipamorelin activates the GHS-R1a receptor, a seven-transmembrane G protein-coupled receptor. Upon ligand binding, GHS-R1a couples primarily to Gαq/11, activating phospholipase C and generating IP3 and DAG second messengers. This leads to calcium release from intracellular stores and protein kinase C activation, triggering GH vesicle exocytosis from somatotrophs. The GHS-R1a receptor also exhibits constitutive (ligand-independent) activity of approximately 50% of maximal signaling, which is unique among peptide hormone receptors. For laboratory research use only.

Howard AD et al. “A receptor in pituitary and hypothalamus that functions in downstream signaling release.” Science. 1996. PubMed

GHS-R1a and Enteric Nervous System Research

GHS-R1a receptors are expressed on enteric neurons in addition to pituitary somatotrophs. In rodent models, ipamorelin modulated gastrointestinal motility patterns through GHS-R1a activation on myenteric plexus neurons, influencing cholinergic signaling pathways. These prepublished studies characterize the enteric receptor distribution and downstream signaling mechanisms of GH-axis secretagogues in the GI tract. For laboratory research use only.

Greenwood-Van Meerveld B et al. “Ipamorelin, a ghrelin mimetic, modulates gastric motility in rodents.” Eur J Pharmacol. 2007. PubMed

Continue reviewing Ipamorelin

Use the research references above alongside Panda’s batch documentation and catalog specifications.

Disclaimer: All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use only. This page is provided for research-reference and documentation review only.

Reviewed by

James S.

Research content reviewer focused on peptide literature summaries, source quality, and reference clarity.

Editorial Review

Reviewed by Elizabeth D. and James S. — Panda Peptides Research Team.

Last reviewed: May 2026.

This content summarizes published laboratory literature for research-reference purposes only. Products referenced by Panda Peptides are sold strictly for controlled laboratory, analytical, or reference use and are not consumer products.